Journals / Türk Toraks Dergisi / 2011 / Cilt: 12 - Sayı: 3

Pulmonary lymphangioleiomyomatosis: A rare, diffuse parenchymal lung disease

Pulmoner lenfanjiyoleiomyomatozis: Nadir görülen yaygın parankimal akciğer hastalığı

Pages
124–126
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here we presented 3 cases that were diagnosed as LAM by surgical pathology. (Tur Toraks Der 2011; 12: 124-6)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary lymphangioleiomyomatosis (LAM) is a rare disease affecting fertile women and is characterized by progressive dyspnea on exertion.
📊
Key Findings & Data:Clinically, it could also be characterized by recurrent pneumothorax, haemoptysis or chylous pleural effusions.
💡
Conclusion & Impact:Here we presented 3 cases that were diagnosed as LAM by surgical pathology. (Tur Toraks Der 2011; 12: 124-6)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Pulmonary lymphangioleiomyomatosis (LAM) is a rare disease affecting fertile women and is characterized by progressive dyspnea on exertion. Clinically, it could also be characterized by recurrent pneumothorax, haemoptysis or chylous pleural effusions. It is characterized by peribronchial, perivascular, and perilymphatic proliferation of atypical smooth muscle, resulting in vascular and airway obstruction, cyst formation, and a progressive decline in lung function. The diagnosis of LAM usually requires an open lung biopsy. Here we presented 3 cases that were diagnosed as LAM by surgical pathology. (Tur Toraks Der 2011; 12: 124-6)

Özet

Pulmoner lenfanjiyoleiyomyomatozis (LAM) üreme çağındaki kadınlarda görülen nadir bir hastalıktır. Eforla artan ilerleyici nefes darlığına yol açar. Klinik olarak tekrarlayıcı pnömotoraks, hemoptizi veya şilöz plevral efüzyon ile de seyredebilmektedir. LAM; damar ve havayolu tıkanmasına, kist oluşumu ve akciğer fonksiyonlarında ilerleyici bozulmaya yol açan, peribronşial, perivasküler ve perilenfatik atipik düz kas proliferasyonu ile karakterizedir. LAM tanısı için sıklıkla açık akciğer biyopsisi gereklidir. Yazımızda, açık akciğer biyopsisi ile tanı konulan 3 lenfanjiyoleiyomyomatozis olgusu sunulmuştur. (Tur Toraks Der 2011; 12: 124-6)

🔖

Cite This Article

CANSEVER, L., KOCATÜRK, C. İ., ŞAHİN, F., YILDIZ, P., BEDİRHAN, M. A. (2011). Pulmonary lymphangioleiomyomatosis: A rare, diffuse parenchymal lung disease. Türk Toraks Dergisi, Cilt: 12 - Sayı: 3, 124–126. https://ajindex.com/articles/329586

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Johnson SR, Whale CI, Hubbard RB, et al. Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax 2004;59:800-3. [CrossRef] 2. Taveira-DaSilva AM, Stylianou MP, Hedin CJ, Hathaway O, Moss J. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest 2004;126:1867-74. [CrossRef] 3. Oh YM, Mo EK, Jang SH, et al. Pulmonary lymphangioleiomyomatosis in Korea. Thorax 1999;54:618-21. [CrossRef] 4. Eliasson AH, Phillips YY, Tenholder MF. Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest 1989;196:1342-55. [CrossRef] 5. Johnson SR. Lymphangioleiomyomatosis. Eur Respir J 2006;27:1056-65. [CrossRef] 6. Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000;55:1052-7. [CrossRef] 7. Matsui K, Tatsuguchi A, Valencia J, et al. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol 2000;31:1242-8. [CrossRef] 8. McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest 2008;133:507-16. [CrossRef] 9. Knight H, Ponn RB. Diffuse lung disease. In: Shields TW. General thoracic surgery. Philadelphia, USA. Lippincott Williams and Wilkins 2005;1363-4. 10. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-56. [CrossRef] 11. Chu SC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999;115:1041-52. [CrossRef]